Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Aug 7:11:e51716.
doi: 10.2196/51716.

Assessing the Short-Term Efficacy of Digital Cognitive Behavioral Therapy for Insomnia With Different Types of Coaching: Randomized Controlled Comparative Trial

Affiliations
Randomized Controlled Trial

Assessing the Short-Term Efficacy of Digital Cognitive Behavioral Therapy for Insomnia With Different Types of Coaching: Randomized Controlled Comparative Trial

Wai Sze Chan et al. JMIR Ment Health. .

Abstract

Background: Digital cognitive behavioral therapy for insomnia (dCBTi) is an effective intervention for treating insomnia. The findings regarding its efficacy compared to face-to-face cognitive behavioral therapy for insomnia are inconclusive but suggest that dCBTi might be inferior. The lack of human support and low treatment adherence are believed to be barriers to dCBTi achieving its optimal efficacy. However, there has yet to be a direct comparative trial of dCBTi with different types of coaching support.

Objective: This study examines whether adding chatbot-based and human coaching would improve the treatment efficacy of, and adherence to, dCBTi.

Methods: Overall, 129 participants (n=98, 76% women; age: mean 34.09, SD 12.05 y) whose scores on the Insomnia Severity Index [ISI] were greater than 9 were recruited. A randomized controlled comparative trial with 5 arms was conducted: dCBTi with chatbot-based coaching and therapist support (dCBTi-therapist), dCBTi with chatbot-based coaching and research assistant support, dCBTi with chatbot-based coaching only, dCBTi without any coaching, and digital sleep hygiene and self-monitoring control. Participants were blinded to the condition assignment and study hypotheses, and the outcomes were self-assessed using questionnaires administered on the web. The outcomes included measures of insomnia (the ISI and the Sleep Condition Indicator), mood disturbances, fatigue, daytime sleepiness, quality of life, dysfunctional beliefs about sleep, and sleep-related safety behaviors administered at baseline, after treatment, and at 4-week follow-up. Treatment adherence was measured by the completion of video sessions and sleep diaries. An intention-to-treat analysis was conducted.

Results: Significant condition-by-time interaction effects showed that dCBTi recipients, regardless of having any coaching, had greater improvements in insomnia measured by the Sleep Condition Indicator (P=.003; d=0.45) but not the ISI (P=.86; d=-0.28), depressive symptoms (P<.001; d=-0.62), anxiety (P=.01; d=-0.40), fatigue (P=.02; d=-0.35), dysfunctional beliefs about sleep (P<.001; d=-0.53), and safety behaviors related to sleep (P=.001; d=-0.50) than those who received digital sleep hygiene and self-monitoring control. The addition of chatbot-based coaching and human support did not improve treatment efficacy. However, adding human support promoted greater reductions in fatigue (P=.03; d=-0.33) and sleep-related safety behaviors (P=.05; d=-0.30) than dCBTi with chatbot-based coaching only at 4-week follow-up. dCBTi-therapist had the highest video and diary completion rates compared to other conditions (video: 16/25, 60% in dCBTi-therapist vs <3/21, <25% in dCBTi without any coaching), indicating greater treatment adherence.

Conclusions: Our findings support the efficacy of dCBTi in treating insomnia, reducing thoughts and behaviors that perpetuate insomnia, reducing mood disturbances and fatigue, and improving quality of life. Adding chatbot-based coaching and human support did not significantly improve the efficacy of dCBTi after treatment. However, adding human support had incremental benefits on reducing fatigue and behaviors that could perpetuate insomnia, and hence may improve long-term efficacy.

Trial registration: ClinicalTrials.gov NCT05136638; https://www.clinicaltrials.gov/study/NCT05136638.

Keywords: chatbot-based coaching; cognitive behavioral therapy; digital intervention; human support; insomnia; mHealth; mobile health; mobile phone.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: TK is affiliated with the Centre for Digital Health Interventions, a joint initiative of the Institute for Implementation Science in Health Care at the University of Zurich; the Department of Management, Technology, and Economics at ETH Zurich; the Future Health Technologies Program at the Singapore-ETH Centre; and the School of Medicine and Institute of Technology Management at the University of St Gallen. The Centre for Digital Health Interventions is funded in part by CSS, a Swiss health insurer; Mavie Next (owned by the UNIQA Group), an Austrian care provider; and MTIP, a Swiss investor company. TK is also a cofounder of Pathmate Technologies, a university spin-off company that creates and delivers digital clinical pathways. However, CSS, Pathmate Technologies, Mavie Next, and MTIP were not involved in this research. All other authors declare no other conflicts of interest.

Figures

Figure 1
Figure 1
CONSORT (Consolidated Standards of Reporting Trials) flowchart of participants. dCBTi: digital cognitive behavioral therapy for insomnia.
Figure 2
Figure 2
Changes in outcomes from baseline to follow-up. Error bars indicate the SEs, “a” indicates significant group-by-time effects of digital cognitive behavioral therapy for insomnia (dCBTi) versus digital sleep hygiene and self-monitoring control (dSH), “b” indicates significant group-by-time effects of dCBTi with human (therapist or research assistant) support versus dCBTi with chatbot-based coaching only (dCBTi-chatbot), and “c” indicates significant group-by-time effects of dCBTi with chatbot-based coaching and therapist support (dCBTi-therapist) versus dCBTi with chatbot-based coaching and research assistant support (dCBTi-assistant). DBAS-16: Dysfunctional Beliefs and Attitudes About Sleep-16; ESS: Epworth Sleepiness Scale; FAS: Fatigue Assessment Scale; GAD-7: Generalized Anxiety Disorder-7; ISI: Insomnia Symptom Index; PHQ-9: Patient Health Questionnaire-9; SCI: Sleep Condition Indicator; SRBQ: Sleep-Related Behaviors Questionnaire; SWLS: Satisfaction With Life Scale.

Similar articles

Cited by

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) Washington, DC: American Psychiatric Association Publishing; 2013.
    1. The AASM International Classification of Sleep Disorders – Third Edition, Text Revision (ICSD-3-TR) American Academy of Sleep Medicine. [2024-06-17]. https://aasm.org/clinical-resources/international-classification-sleep-d...
    1. Aernout E, Benradia I, Hazo JB, Sy A, Askevis-Leherpeux F, Sebbane D, Roelandt JL. International study of the prevalence and factors associated with insomnia in the general population. Sleep Med. 2021 Jun;82:186–92. doi: 10.1016/j.sleep.2021.03.028.S1389-9457(21)00199-4 - DOI - PubMed
    1. Lam CS, Yu BY, Cheung DS, Cheung T, Lam SC, Chung KF, Ho FY, Yeung WF. Sleep and mood disturbances during the COVID-19 outbreak in an urban Chinese population in Hong Kong: a longitudinal study of the second and third waves of the outbreak. Int J Environ Res Public Health. 2021 Aug 10;18(16):8444. doi: 10.3390/ijerph18168444. https://www.mdpi.com/resolver?pii=ijerph18168444 ijerph18168444 - DOI - PMC - PubMed
    1. Morin CM, Bjorvatn B, Chung F, Holzinger B, Partinen M, Penzel T, Ivers H, Wing YK, Chan NY, Merikanto I, Mota-Rolim S, Macêdo T, De Gennaro L, Léger D, Dauvilliers Y, Plazzi G, Nadorff MR, Bolstad CJ, Sieminski M, Benedict C, Cedernaes J, Inoue Y, Han F, Espie CA. Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study. Sleep Med. 2021 Nov;87:38–45. doi: 10.1016/j.sleep.2021.07.035. https://europepmc.org/abstract/MED/34508986 S1389-9457(21)00419-6 - DOI - PMC - PubMed

Publication types

Associated data